Atlas Trials

Relapsed/Refractory Pancreatic Ductal Adenocarcinoma

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed/Refractory Pancreatic Ductal Adenocarcinoma

RecordFirmDate
Study of Single Agent Idelalisib Followed by Idelalisib in Combination With Chemotherapy in Adults With Metastatic Pancreatic Ductal Adenocarcinoma (NCT02468557)Gilead Sciences2015-07-30

Track Relapsed/Refractory Pancreatic Ductal Adenocarcinoma automatically

Every clearance here is in the API, with alerts when new ones post.